Page last updated: 2024-10-24

camostat and Neutropenia

camostat has been researched along with Neutropenia in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitsuoka, H1
Kistler, EB1
Schmid-Schönbein, GW1

Other Studies

1 other study available for camostat and Neutropenia

ArticleYear
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
    Shock (Augusta, Ga.), 2002, Volume: 17, Issue:3

    Topics: Animals; Blood Pressure; Endopeptidases; Esters; Gabexate; Guanidines; Humans; In Vitro Techniques;

2002